Photo: Depositphotos
Jun 28, 2025, 09:05
IARC Evaluates Carcinogenicity of HDV, HCMV, and MCPyV
IARC – International Agency for Research on Cancer / World Health Organization posted on LinkedIn:
“IARC has evaluated the carcinogenicity of hepatitis D virus (HDV), human cytomegalovirus (HCMV), and Merkel cell polyomavirus (MCPyV). The outcome of the assessment has been published in a summary article in The Lancet Group Oncology.
HDV and MCPyV were previously evaluated by the IARC Monographs programme in Volumes 59 and 104, respectively. HCMV was evaluated for the first time.”
More posts featuring IARC on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 7, 2025, 16:47
Sep 7, 2025, 16:30
Sep 7, 2025, 16:25